fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Night time blood pressure may increase Alzheimer’s disease risk

Written by | 14 Feb 2021

Higher blood pressure at night than in daytime may be a risk factor for Alzheimer’s disease in older men.

EU approves Rukobia for HIV-1 infection – ViiV Healthcare

Written by | 13 Feb 2021

ViiV Healthcare, owned by GlaxoSmithKline, announced the European Marketing Authorisation of Rukobia (fostemsavir) 600mg extended-release tablets..

Higher blood pressure over life span increases congestive heart failure risk in Black people

Written by | 13 Feb 2021

Starting with early childhood, otherwise healthy Black people show signs of slightly diminished heart muscle strength and a slightly higher blood pressure than their white counterparts..

CHMP recommends approval of Ontozry for focal – onset (partial-onset) seizures – SK Biopharmaceuticals

Written by | 12 Feb 2021

SK Biopharmaceuticals announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use.

Cannabis reduces blood pressure in older adults

Written by | 12 Feb 2021

A new discovery by researchers from Ben-Gurion University of the Negev (BGU) and its affiliated Soroka University Medical Center shows that medical cannabis may reduce blood pressure in… read more.

COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials

Written by | 11 Feb 2021

The primary analysis of the Phase III clinical trials from the UK, Brazil and South Africa, published as a preprint in The Lancet confirmed COVID-19 Vaccine AstraZeneca is… read more.

Frequent cannabis use by young people linked to decline in IQ

Written by | 11 Feb 2021

A study has found that adolescents who frequently use cannabis may experience a decline in Intelligence Quotient (IQ) over time.

EU approves Trimbow for asthma – Chiesi

Written by | 10 Feb 2021

The European Commission has approved a marketing authorisation for triple combination Trimbow (beclometasone + formoterol + glycopyrronium) from Chiesi, for patiemts with asthma therapy.

Heparin targets coronavirus spike protein, research shows

Written by | 10 Feb 2021

An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the… read more.

FDA approves intramuscular injection route of administration of Plegridy for multiple sclerosis – Biogen

Written by | 9 Feb 2021

Biogen Inc. announced that the FDA has approved a new intramuscular (IM) injection route of administration for Plegridy (peginterferon beta-1a) for the treatment of relapsing forms of multiple… read more.

Study estimates that, without vaccination, mortality in children under five would be 45% higher in low-income and middle-income countries

Written by | 9 Feb 2021

A new modelling study has estimated that from 2000 to 2030 vaccination against 10 major pathogens

CHMP recommends once-weekly Sogroya to treat growth hormone deficiency – Novo Nordisk

Written by | 8 Feb 2021

Novo Nordisk announced that the Committee for Medicinal Products for Human Use (CHMP), under the European Medicines Agency (EMA), adopted a positive opinion for the use of once-weekly… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.